1. Home
  2. PDS vs JANX Comparison

PDS vs JANX Comparison

Compare PDS & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Drilling Corporation

PDS

Precision Drilling Corporation

HOLD

Current Price

$84.63

Market Cap

992.1M

Sector

N/A

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$16.12

Market Cap

975.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDS
JANX
Founded
1951
2017
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
992.1M
975.7M
IPO Year
1998
2021

Fundamental Metrics

Financial Performance
Metric
PDS
JANX
Price
$84.63
$16.12
Analyst Decision
Strong Buy
Buy
Analyst Count
3
13
Target Price
$122.33
$47.00
AVG Volume (30 Days)
95.8K
688.7K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,000,000.00
Revenue This Year
$5.66
N/A
Revenue Next Year
$2.31
N/A
P/E Ratio
$884.15
N/A
Revenue Growth
N/A
N/A
52 Week Low
$52.53
$12.12
52 Week High
$103.80
$35.34

Technical Indicators

Market Signals
Indicator
PDS
JANX
Relative Strength Index (RSI) 57.31 53.93
Support Level $83.72 $13.13
Resistance Level $86.80 $16.68
Average True Range (ATR) 2.91 0.65
MACD 0.98 0.03
Stochastic Oscillator 92.64 67.55

Price Performance

Historical Comparison
PDS
JANX

About PDS Precision Drilling Corporation

Precision Drilling Corp is a provider of contract drilling, completion, and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. The company operates through two industry segments: Contract Drilling Services, which generates maximum revenue and includes drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale, and repair of drilling equipment; and Completion and Production Services, which includes service rigs, oilfield equipment rental, and camp services. The company generates the majority of its revenue from the United States.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: